Risk factors for death from Stenotrophomonas maltophilia bacteremia

• Published in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy Vol. 24; no. 8; pp. 632 - 636
• Main Authors: Osawa, Kayo, Shigemura, Katsumi, Kitagawa, Koichi, Tokimatsu, Issei, Fujisawa, Masato
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 01-08-2018
• Subjects: Bacteremia; Infection control: risk factor; Stenotrophomonas maltophilia; Stenotrophomonas maltophilia; Infection control: risk factor; Bacteremia
• ISSN: 1341-321X; 1437-7780
• DOI: 10.1016/j.jiac.2018.03.011

Stenotrophomonas maltophilia has low pathogenicity potential, but if it causes bacteremia it can be fatal, because it has shown high resistance to many antibiotics and can be difficult to treat. Patient death from S. maltophilia bacteremia has increased since 2014 in our hospital. In this study, we investigated risk factors for death due to S. maltophilia bacteremia.
Seventy patients from the hospital database with S. maltophilia bacteremia between January 2010 and July 2017 were investigated. We retrospectively analyzed risk factors including gender, age, wards, hospitalized duration, clinical history, devices, source of S. maltophilia identification, polymicrobial bacteremia, prior antimicrobial therapy, antimicrobial therapy after bacteremia, and resistance to antibiotics. The statistical analysis was performed to compare the period from 2010 to 2013 to from 2014 to 2017.
Comparing the 2010–2013 period to the 2014–2017 period, it revealed that history of hospitalization, identification of S. maltophilia from sputum, polymicrobial bacteremia, prior carbapenem use, and mortality was significantly different in S. maltophilia bacteremia (p = 0.028, p = 0.004, p < 0.001, p = 0.034, and p = 0.007, respectively). Comparison between non-survivors and survivors for 2010–2013 and 2014–2017 found ICU admission and ventilator use were seen more often in non-survivors (p = 0.030 vs p = 0.013 and p = 0.027 vs p = 0.010, respectively).
Our analyses showed increase in mortality from S. maltophilia bacteremia from 2014 to 2017, and that non-survivors had a higher frequency of ICU admission and ventilator use in both the 2010–2013 and 2014–2017 periods. There were more combination antimicrobial therapy cases after bacteremia in 2014–2017. Further prospective studies with larger numbers of patients should be undertaken for definitive conclusions.